Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
After finishing at $345.46 in the prior trading day, AMGEN Inc (NASDAQ: AMGN) closed at $337.49, down -2.31%. In other words, the price has decreased by -$2.31 from its previous closing price. On the day, 2.34 million shares were traded. AMGN stock price reached its highest trading level at $343.7911 during the session, while it also had its lowest trading level at $336.25.
Ratios:
Our goal is to gain a better understanding of AMGN by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 19.24 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.75. For the most recent quarter (mrq), Quick Ratio is recorded 0.99 and its Current Ratio is at 1.28. In the meantime, Its Debt-to-Equity ratio is 5.67 whereas as Long-Term Debt/Eq ratio is at 5.45.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 20 ’25 when Grygiel Nancy A. sold 3,139 shares for $337.26 per share. The transaction valued at 1,058,667 led to the insider holds 7,225 shares of the business.
Grygiel Nancy A. bought 3,139 shares of AMGN for $1,058,667 on Nov 20 ’25. On Nov 12 ’25, another insider, Khosla Rachna, who serves as the SVP, Business Development of the company, sold 890 shares for $336.24 each. As a result, the insider received 299,256 and left with 7,082 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AMGN now has a Market Capitalization of 181731819520 and an Enterprise Value of 226873835520. As of this moment, AMGEN’s Price-to-Earnings (P/E) ratio for their current fiscal year is 26.09, and their Forward P/E ratio for the next fiscal year is 15.40. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 5.55. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.06 while its Price-to-Book (P/B) ratio in mrq is 18.89. Its current Enterprise Value per Revenue stands at 6.307 whereas that against EBITDA is 13.766.
Stock Price History:
The Beta on a monthly basis for AMGN is 0.45, which has changed by 0.21259701 over the last 52 weeks, in comparison to a change of 0.12607694 over the same period for the S&P500. Over the past 52 weeks, AMGN has reached a high of $345.84, while it has fallen to a 52-week low of $253.30. The 50-Day Moving Average of the stock is 9.79%, while the 200-Day Moving Average is calculated to be 14.08%.
Shares Statistics:
The stock has traded on average 2.58M shares per day over the past 3-months and 2781120 shares per day over the last 10 days, according to various share statistics. A total of 538.50M shares are outstanding, with a floating share count of 537.46M. Insiders hold about 0.19% of the company’s shares, while institutions hold 81.30% stake in the company. Shares short for AMGN as of 1763078400 were 13363223 with a Short Ratio of 5.17, compared to 1760486400 on 11478293. Therefore, it implies a Short% of Shares Outstanding of 13363223 and a Short% of Float of 2.4899999999999998.
Dividends & Splits
In the trailing 12 months, AMGN’s forward annual dividend rate was 9.39, compared to 9.52 this year. Against a Trailing Annual Dividend Yield of 0.027181152. The stock’s 5-year Average Dividend Yield is 3.06. The current Payout Ratio is 119.05% for AMGN, which recently paid a dividend on 2025-11-21 with an ex-dividend date of 2025-11-21. Stock splits for the company last occurred on 1999-11-22 when the company split stock in a 2:1 ratio.
Earnings Estimates
Currently, 25.0 analysts are dedicated to thoroughly evaluating and rating the performance of AMGEN Inc (AMGN) in the stock market.The consensus estimate for the next quarter is $5.06, with high estimates of $6.55 and low estimates of $4.41.
Analysts are recommending an EPS of between $22.3 and $20.6 for the fiscal current year, implying an average EPS of $21.24. EPS for the following year is $21.86, with 31.0 analysts recommending between $24.49 and $20.33.
Revenue Estimates
22 analysts predict $9.46B in revenue for. The current quarter. It ranges from a high estimate of $9.87B to a low estimate of $8.98B. As of. The current estimate, AMGEN Inc’s year-ago sales were $9.09BFor the next quarter, 22 analysts are estimating revenue of $8.66B. There is a high estimate of $8.97B for the next quarter, whereas the lowest estimate is $8.22B.
A total of 28 analysts have provided revenue estimates for AMGN’s current fiscal year. The highest revenue estimate was $36.76B, while the lowest revenue estimate was $35.87B, resulting in an average revenue estimate of $36.33B. In the same quarter a year ago, actual revenue was $33.42BBased on 31 analysts’ estimates, the company’s revenue will be $36.85B in the next fiscal year. The high estimate is $38.74B and the low estimate is $35.3B.
